|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.08 USD | +3.61% |
|
+12.30% | +14.48% |
| Apr. 23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
| Apr. 23 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
Kiniksa Pharmaceuticals, Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 79.86 million compared to USD 48.35 million a year ago. Net loss was USD 17.7 million compared to USD 12.27 million a year ago.
Basic loss per share from continuing operations was USD 0.25 compared to USD 0.18 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +14.48% | 1.42B | |
| -1.43% | 104B | |
| +8.96% | 105B | |
| +4.40% | 22.94B | |
| -12.15% | 22.34B | |
| -4.36% | 19.25B | |
| -39.98% | 17.08B | |
| -10.04% | 16.96B | |
| +6.79% | 14.16B | |
| +38.61% | 12.63B |
KINIKSA PHARMACEUTICALS, LTD. 
